ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志

• 论文 • 上一篇    下一篇

间充质干细胞治疗糖尿病肾病

  

  • 出版日期:2019-10-28 发布日期:2020-01-07

Mesenchymal stem cells treatment for diabetic nephropathy

  • Online:2019-10-28 Published:2020-01-07

摘要: 糖尿病肾病是糖尿病的主要微血管并发症,也是许多终末期肾病的重要病因,伴随严重肾损害的同时增加了心血管疾病的危险。其发病机制相当复杂,主要病理改变为细胞外基质沉积,肾小球基膜增厚、肾小球硬化和系膜扩张以及纤维化。间充质干细胞疗法作为治疗糖尿病肾病十分有前景的治疗方案,除了具有多分化潜能和自我更新能力外,旁分泌功能十分重要。本文综述了间充质干细胞治疗糖尿病肾病的潜力,主要为间充质干细胞旁分泌营养因子和细胞外囊泡的机制。对间充质干细胞治疗糖尿病肾病机制的探讨可为该病的临床治疗提供新的治疗策略。

关键词: 糖尿病肾病, 间充质干细胞旁, 分泌, 营养因子, 细胞外囊泡

Abstract: Diabetic nephropathy(DN) is the main microvascular complication of diabetes and the primary cause of many endstage renal disease,increasing the risk of cardiovascular disease at the same time.The pathogenesis is quite complex,and the main pathological changes are extracellular matrix deposition,glomerular basement membrane thickening,glomerular and mesangial dilatation,and fibrosis.Mesenchymal stem cells (MSC) therapy is a promising treatment for DN.In addition to its multidifferentiation potential and selfrenewal ability,the paracrine function is very important.This article reviews the potential of mesenchymal stem cells in the treatment of DN,mainly for the mechanism of paracrine trophic factors and extracellular vesicles of mesenchymal stem cells.Discussion on the mechanism of mesenchymal stem cells in the treatment of DN may provide a new therapeutic strategy for the clinical treatment of the disease